BRPI0408323A - processo para a preparação de compimidos de liberação prolongada - Google Patents

processo para a preparação de compimidos de liberação prolongada

Info

Publication number
BRPI0408323A
BRPI0408323A BRPI0408323-7A BRPI0408323A BRPI0408323A BR PI0408323 A BRPI0408323 A BR PI0408323A BR PI0408323 A BRPI0408323 A BR PI0408323A BR PI0408323 A BRPI0408323 A BR PI0408323A
Authority
BR
Brazil
Prior art keywords
present
release
pharmaceutical composition
preparation
sustained release
Prior art date
Application number
BRPI0408323-7A
Other languages
English (en)
Inventor
Nirmal Mulye
Original Assignee
Nirmal Mulye
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nirmal Mulye filed Critical Nirmal Mulye
Publication of BRPI0408323A publication Critical patent/BRPI0408323A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"PROCESSO PARA A PREPARAçãO DE COMPRIMIDOS DE LIBERAçãO PROLONGADA". A presente invenção se refere a um novo processo para a preparação de comprimidos de liberação prolongada contendo compostos medicinais e aos produtos preparados por esse processo. A presente invenção se refere a um processo de preparação de uma composição farmacêutica de liberação prolongada com um perfil predeterminado de liberação de medicamento, mas que se desvie dele pela adição de uma quantidade eficaz para a formação de comprimidos de uma celulose insolúvel ou parcialmente insolúvel em água à composição farmacêutica, composta por um medicamento em uma quantidade terapeuticamente eficaz, um veículo de liberação prolongada, presente em quantidades eficaz para retardar a liberação do medicamento da composição farmacêutica, e a celulose, esta última estando presente em um sistema aquoso, o aperfeiçoamento compreendendo a adição à composição de uma quantidade eficaz de maltodextrina para retardar o aumento da taxa de liberação do medicamento pela adição da celulose a ele.
BRPI0408323-7A 2003-03-14 2004-03-15 processo para a preparação de compimidos de liberação prolongada BRPI0408323A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45480303P 2003-03-14 2003-03-14
PCT/US2004/007826 WO2004082615A2 (en) 2003-03-14 2004-03-15 A process for preparing sustained release tablets

Publications (1)

Publication Number Publication Date
BRPI0408323A true BRPI0408323A (pt) 2006-03-07

Family

ID=33029912

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0408323-7A BRPI0408323A (pt) 2003-03-14 2004-03-15 processo para a preparação de compimidos de liberação prolongada

Country Status (9)

Country Link
US (2) US20040224017A1 (pt)
EP (1) EP1603540A2 (pt)
JP (1) JP2006520390A (pt)
AU (1) AU2004222339A1 (pt)
BR (1) BRPI0408323A (pt)
CA (1) CA2518734A1 (pt)
MX (1) MXPA05009886A (pt)
NZ (1) NZ542303A (pt)
WO (1) WO2004082615A2 (pt)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
AU764453B2 (en) 1999-10-29 2003-08-21 Euro-Celtique S.A. Controlled release hydrocodone formulations
CN101317825A (zh) 2000-10-30 2008-12-10 欧罗赛铁克股份有限公司 控释氢可酮制剂
CA2359812C (en) 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
BRPI0408323A (pt) * 2003-03-14 2006-03-07 Nirmal Mulye processo para a preparação de compimidos de liberação prolongada
CA2544816A1 (en) 2003-11-08 2005-05-26 Prothera Biologics, Llc Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use
AU2004305293A1 (en) * 2003-12-23 2005-07-07 Temrel Limited Process for producing pellets for pharmaceutical compositions
MXPA06010047A (es) * 2004-03-10 2007-03-07 Taisho Pharma Co Ltd Preparacion farmaceutica solida que contiene farmaco escasamente soluble en agua.
RU2007143556A (ru) * 2005-04-25 2009-06-10 ТЕВА ФАРМАСЬЮТИКАЛЗ ЮЭсЭй, ИНК. (US) Композиции с пролонгированным высвобождением
US20100227916A1 (en) * 2006-05-19 2010-09-09 Somaxon Pharmaceuticals, Inc N-desmethyl-doxepin and methods of using the same to treat sleep disorders
US20100179215A1 (en) 2006-05-19 2010-07-15 Somaxon Pharmaceuticals, Inc. Doxepin isomers and isomeric mixtures and methods of using the same to treat sleep disorders
WO2007136845A2 (en) 2006-05-19 2007-11-29 Somaxon Pharmaceuticals, Inc. Low-dose doxepin for treatment of sleep disorders in elderly patients
WO2007142810A2 (en) 2006-05-19 2007-12-13 Somaxon Pharmaceuticals, Inc. Methods of using low-dose doxepin for the improvement of sleep
US20100179214A1 (en) 2006-05-19 2010-07-15 Somaxon Pharmaceuticals, Inc. Doxepin trans isomers and isomeric mixtures and methods of using the same to treat sleep disorders
US20080069891A1 (en) * 2006-09-15 2008-03-20 Cima Labs, Inc. Abuse resistant drug formulation
WO2008011150A1 (en) 2006-07-20 2008-01-24 Somaxon Pharmaceuticals, Inc. Methods of improving the pharmacokinetics of doxepin
US8445018B2 (en) * 2006-09-15 2013-05-21 Cima Labs Inc. Abuse resistant drug formulation
WO2008052139A2 (en) 2006-10-25 2008-05-02 Somaxon Pharmaceuticals, Inc. Ultra low dose doxepin and methods of using the same to treat sleep disorders
US20110077200A1 (en) 2006-12-06 2011-03-31 Somaxon Pharmaceuticals, Inc. Combination therapy using low-dose doxepin for the improvement of sleep
WO2008073282A2 (en) * 2006-12-07 2008-06-19 Schering Corporation Ph sensitive matrix formulation
EP2148659A2 (en) 2007-04-13 2010-02-03 Somaxon Pharmaceuticals, Inc. Low-dose doxepin formulations
US20090036414A1 (en) * 2007-08-02 2009-02-05 Mutual Pharmaceutical Company, Inc. Mesalamine Formulations
WO2009042114A2 (en) 2007-09-21 2009-04-02 The Johns Hopkins University Phenazine derivatives and uses thereof
EP2203056A1 (en) * 2007-09-25 2010-07-07 Nirmal Mulye Controlled release pharmaceutical compositions
WO2009085306A1 (en) * 2007-12-28 2009-07-09 Impax Laboratories, Inc. Controlled release formulations of levodopa and uses thereof
BRPI0913949A2 (pt) * 2008-05-28 2015-10-20 Pro Thera Biolog Llc preparação e composição de proteínas inibidoras inter-alfa a partir de sangue
CA2798702A1 (en) 2010-05-11 2011-11-17 Cima Labs Inc. Alcoholresistant metoprolol-containing extended-release oral dosage forms
AU2012327231B2 (en) * 2011-12-09 2015-09-24 Purdue Pharma L.P. Pharmaceutical dosage forms comprising poly(epsilon-caprolactone) and polyethylene oxide
CN114146079A (zh) * 2012-02-07 2022-03-08 比奥根玛公司 含有富马酸二甲酯的药物组合物
WO2014039987A2 (en) 2012-09-09 2014-03-13 Prothera Biologics, Inc. Treatment of disease using inter-alpha inhibitor proteins
EP3272837B1 (en) * 2016-07-21 2021-01-27 Bharat Petroleum Corporation Limited Fuel composition containing lubricity improver and method thereof
JP2021512924A (ja) * 2018-02-08 2021-05-20 タイワンジェ ファーマシューティカルズ カンパニー リミテッドＴａｉｗａｎｊ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｃｏ．， Ｌｔｄ． オピオイド受容体拮抗薬の固体剤形の医薬製剤

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4792452A (en) * 1987-07-28 1988-12-20 E. R. Squibb & Sons, Inc. Controlled release formulation
US5057321A (en) * 1990-06-13 1991-10-15 Alza Corporation Dosage form comprising drug and maltodextrin
US5773031A (en) * 1996-02-27 1998-06-30 L. Perrigo Company Acetaminophen sustained-release formulation
ES2248908T7 (es) * 1997-06-06 2014-11-24 Depomed, Inc. Formas de dosificación de fármacos por vía oral y retención gástrica para liberación continuada de fármacos altamente solubles
PT991409E (pt) * 1997-08-01 2002-06-28 Elan Corp Plc Composicoes farmaceuticas de libertacao controlada contendo tiagabina
WO1999007342A1 (en) * 1997-08-11 1999-02-18 Alza Corporation Prolonged release active agent dosage form adapted for gastric retention
US6056977A (en) * 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation
FR2772615B1 (fr) * 1997-12-23 2002-06-14 Lipha Comprime multicouche pour la liberation instantanee puis prolongee de substances actives
FI980901A (fi) * 1998-04-23 1999-10-24 Orion Yhtymae Oyj Levosimendaania säädellysti vapauttavia oraalisia koostumuksia
US6368625B1 (en) * 1998-08-12 2002-04-09 Cima Labs Inc. Orally disintegrable tablet forming a viscous slurry
US6117451A (en) * 1998-08-25 2000-09-12 Pharmalogix, Inc. Direct compression metformin hydrochloride tablets
CA2354057C (en) * 1998-12-11 2009-02-10 Nostrum Pharmaceuticals, Inc. Sustained release tablet containing hydrocolloid and cellulose ether
CZ20012201A3 (cs) * 1998-12-18 2001-09-12 Abbott Laboratories Přípravek s řízeným uvolňováním obsahující divalproex sodný
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
CO5210862A1 (es) * 1999-09-15 2002-10-30 Alza Corp Formas de dosificacion y metodos para proporcionar efectiva terapia de reboxetina con dosificacion de una vez al dia
EP1242057A2 (en) * 1999-11-02 2002-09-25 DepoMed, Inc. Pharmacological inducement of the fed mode for enhanced drug administration to the stomach
CA2393344C (en) * 1999-12-03 2009-09-01 Polichem S.A. Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
DE10014588A1 (de) * 2000-03-27 2001-10-04 Basf Ag Wirkstoffhaltige Schwimmformen enthaltend Polyvinylacetat und Polyvinylpyrrolidon, deren Verwendung und Herstellung
US6399101B1 (en) * 2000-03-30 2002-06-04 Mova Pharmaceutical Corp. Stable thyroid hormone preparations and method of making same
AR030557A1 (es) * 2000-04-14 2003-08-27 Jagotec Ag Una tableta en multicapa de liberacion controlada y metodo de tratamiento
AU2001100195B4 (en) * 2001-01-05 2001-12-20 H Lundbeck As Pharmaceutical composition containing citalopram.
US6544552B2 (en) * 2001-01-11 2003-04-08 Particle And Coating Technologies, Inc. Method of producing porous tablets with improved dissolution properties
EP1226818A1 (en) * 2001-01-26 2002-07-31 Pfizer Products Inc. Pharmaceutical dosage forms with enhanced cohesive and compressibility properties
EP1383376A4 (en) * 2001-03-19 2006-03-08 Praecis Pharm Inc PHARMACEUTICAL FORMULATIONS WITH PROLONGED RELEASE
EP1385486A4 (en) * 2001-04-18 2006-05-17 Nostrum Pharmaceuticals Inc NEW COATING OF SLOW RELEASE PHARMACEUTICAL COMPOSITION
GB0117619D0 (en) * 2001-07-19 2001-09-12 Phoqus Ltd Pharmaceutical dosage form
BRPI0408323A (pt) * 2003-03-14 2006-03-07 Nirmal Mulye processo para a preparação de compimidos de liberação prolongada

Also Published As

Publication number Publication date
MXPA05009886A (es) 2006-05-04
JP2006520390A (ja) 2006-09-07
US20110071137A1 (en) 2011-03-24
AU2004222339A1 (en) 2004-09-30
WO2004082615A3 (en) 2004-11-25
CA2518734A1 (en) 2004-09-30
US20040224017A1 (en) 2004-11-11
WO2004082615A2 (en) 2004-09-30
EP1603540A2 (en) 2005-12-14
NZ542303A (en) 2008-12-24

Similar Documents

Publication Publication Date Title
BRPI0408323A (pt) processo para a preparação de compimidos de liberação prolongada
BRPI0607549A2 (pt) sistemas de distribuição farmacêutica para fármacos hidrófobos e composições compreendendo os mesmos
BR9908488A (pt) Composição farmacêutica de topiramato
BR9913696A (pt) Sistema de liberação de drogas, administrado oralmente, proporcionando controle temporal e espacial
BR0212008A (pt) Uso de um composto ou de um sal, solvato ou pró-medicamento deste, composição farmacêutica, composto ou um sal, solvato ou pró-medicamento deste, e, processo para a preparação deste
BR0211601A (pt) Polimorfo estável de flibanserina, processo técnico para a preparação do mesmo e o uso do mesmo para a preparação de medicamentos
TW200630123A (en) Oral medicinal product with modified release of at least one active principle in multimicrocapsular form
BR0015188A (pt) Composições farmacêuticas
BR0112589A (pt) Derivados de heteroarila e sua aplicação como medicamento
CY1107828T1 (el) Θεραπευτικα βιοπροσκολλητικα συστηματα παρατεταμενης αποδεσμευσης
BR9506029A (pt) Forma farmaêutica oral de múltipla dosagem unitária em tablete processo para a preparação da mesma para a inibição da secreção de ácido gástrico em mamiferos e no homem para o tratamento de doenças inflamatórias gastrointestinais em maniferos e no homem e embalgem de ampola de pressão transversal
HUP0303325A2 (hu) Gyógyászati sók és ezeket tartalmazó gyógyászati készítmények
GT200100183A (es) Derivados de quinolina y quinazolina.
BR0009864A (pt) Composto, composição farmacêutica, métodos para o tratamento de doenças, para o tratamento e/ou prevenção de condições mediadas pelos receptores nucleares e para o tratamento e/ou prevenção de diabete e/ou obesidade, e, uso de um composto
BRPI0717673B8 (pt) composição de oligogalacturonanas, biomaterial e têxtil
BRPI0620229B8 (pt) formulações farmaceuticas e processos de produção da ditas formulações
BR9810197A (pt) Produto, compostos, processo de preparação destes, composição farmacêutica, e, utilização de um produto
NO20082047L (no) Sakte frigivende sammensetning, fremgangsmate for fremstilling derav og anvendelse av samme
BRPI0411413A (pt) composições para revestimento entérico de um produto natural e de microcápsulas com revestimento entérico contendo lectina
BRPI0518789A2 (pt) formulaÇço farmacÊutica, processo para preparar uma formulaÇço farmacÊutica, produto, e, cÁpsula ou tablete
BR112012030641A2 (pt) métodos e composições para terapia farmacêutica oral
BR0211198A (pt) Composições farmacêuticas e seu uso
BR0312728A (pt) Formulação em tablete dispersìvel e processo para sua preparação
BR0008713A (pt) Processos para preparar formulações ecomposições farmacêuticas orais com ecb
BRPI0518790A2 (pt) formulaÇço farmacÊutica, processo para preparar uma formulaÇço farmacÊutica, produto, e, cÁpsula ou tablete

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUI DADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2129 DE 25/10/2011.